New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
18:44 EDTKV.A, HOLXKV Pharmaceutical secures $85M loan for payments under reorganization plan
K-V Pharmaceutical announced that it has received a commitment from lenders led by an affiliate of Silver Point Finance for $85M in senior secured post-petition debtor-in-possession financing, which the company intends to use to, among other things, satisfy the terms of its recently filed settlement agreement with Hologic (HOLX), provide additional financial flexibility during the pendency of the company's Chapter 11 proceeding and fund certain payments under a proposed reorganization plan. The new DIP financing, the Hologic Settlement and the reorganization plan are each subject to approval of the U. S. Bankruptcy Court for the Southern District of New York. The Hologic settlement confirms K-V's continued ownership of Makena and will resolve all bankruptcy related disputes between K-V and Hologic, and provides for mutual releases of all claims between the parties. Under the proposed reorganization plan, K-V expects to emerge from Chapter 11 with its entire product portfolio, including Makena, Clindesse, Gynazole-1 and Evamist.
News For A;HOLX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
14:43 EDTHOLXStocks held by Relational Investors slide after report of wind down
Subscribe for More Information
13:52 EDTHOLXActivist firm Relational winding down, dissolving funds, WSJ says
Subscribe for More Information
September 30, 2014
08:18 EDTAAgilent risk/reward favorable into spin-off, says Leerink
Subscribe for More Information
08:18 EDTAAgilent risk/reward favorable into spin-off, says Leerink
Subscribe for More Information
September 29, 2014
16:20 EDTAAgilent says regulatory authorities close past FCPA probe
Agilent disclosed in a filing that on September 6, 2013, Agilent Technologies disclosed in its Form 10-Q that it had initiated an internal investigation relating to certain sales of company products through third party intermediaries in China and compliance by company employees in China with the requirements of the U.S. Foreign Corrupt Practices Act and other applicable laws and regulations. The company further disclosed that it had voluntarily advised the United States Department of Justice and the United States Securities and Exchange Commission of the investigation. On September 15, the company received a letter from the SECís Division of Enforcement stating that its investigation had been completed and that the Division of Enforcement did not intend to recommend any enforcement action against the company by the SEC. On September 24, the company received a letter from DOJ stating that DOJ had closed its inquiry into the matter, citing the companyís voluntary disclosure and thorough investigation.
11:02 EDTAAgilent announces collaboration with University of Toronto
Agilent announced a collaboration with scientists at the University of Torontoís Donnelly Centre for Cellular and Biomolecular Research to produce a comprehensive metabolomics multiple-reaction monitoring library and methodology, using Agilentís Infinity 1290 UHPLC and 6460 triple quadrupole mass spectrometry system.
September 26, 2014
07:22 EDTAAgilent management to meet with Jefferies
Meeting to be held in the Mid-Atlantic area on October 2 hosted by Jefferies.
September 22, 2014
10:15 EDTHOLXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:32 EDTHOLXHologic upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use